Kade Huntsman, MD
Orthopaedic Surgery of the Spine · Salt Lake City, UTNPI 1730171232
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $1,083,124 of the $1,594,580 with a category attached, or 67.9%. 33 manufacturers reported payments, led by Ortho Development Corporation at 29.2% of the total. Reporting peaked in 2019 at $533,580 and has fallen 77.0% since, to $122,687 in 2025.
Across 895 payments — averaging $1781.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ortho Development Corporation$466K
- Medtronic$409K
- Globus Medical$388K
- Alphatec Spine, Inc$239K
- Osteocentric Technologies, Inc.$42K
- Titan Spine, LLC$19K
- plus $32K from 27 others
Across 21 payments — averaging $1459.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Intrinsic Therapeutics$28K
- Globus Medical$3K
Across 7 payments — averaging $14,284 each. An ownership or investment interest held by the physician or an immediate family member.
- Osteocentric Technologies, Inc.$100K
- Bisurg Distribution, LLC$0
- Titan Spine, LLC$0
What the payments were for
- Royalty or licence$1,083,12468%
- Consulting fees$258,99316%
- Speaking & faculty fees$17,2561%
- Travel & lodging$67,2114%
- Food & beverage$18,4921%
- Entertainment$1730%
- Other$149,3319%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ortho Development Corporation | 309 | $466,310 |
| Medtronic(2 entities) | 34 | $408,545 |
| Globus Medical(2 entities) | 143 | $387,550 |
| Alphatec Spine, Inc | 160 | $239,246 |
| Osteocentric Technologies, Inc. | 60 | $41,900 |
| Titan Spine, LLC | 2 | $19,342 |
| Kuros Biosciences USA, Inc | 10 | $7,586 |
| Intrinsic Therapeutics | 14 | $4,065 |
| Integrity Implants Inc. | 14 | $4,030 |
| Nexxt Spine LLC | 9 | $3,537 |
| Baxter Healthcare | 8 | $3,314 |
| Providence Medical Technology, Inc. | 27 | $2,339 |
| Integrity Implants Inc. Dba Accelus | 3 | $2,241 |
| Bioventus LLC | 3 | $1,312 |
| Orthofix Medical, Inc. | 12 | $1,002 |
| Boston Scientific | 52 | $898 |
| Stryker | 6 | $196 |
| Cerapedics Inc. | 2 | $178 |
| Augmedics Inc. | 2 | $163 |
| Highridge Medical LLC | 1 | $140 |
| Curiteva, Inc. | 2 | $128 |
| Nevro Corp. | 8 | $124 |
| Adcura, Inc. | 1 | $86 |
| Nexus Spine, LLC | 1 | $85 |
| Expanding Innovations, Inc. | 1 | $50 |
| Active Medical, LLC | 2 | $49 |
| Surgalign Spine Technologies, Inc. | 2 | $45 |
| Saluda Medical Americas, Inc. | 1 | $34 |
| Apyx Medical Corporation | 2 | $27 |
| Spinal Simplicity, LLC | 1 | $17 |
| Biocomposites Inc | 1 | $16 |
| Radius Health, Inc. | 1 | $15 |
| Si-bone, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Pagoda$281,420
- Other - Miscellaneous$187,514
- AttraX$185,971
- Modulus$185,971
- IBIS$140,632
- nanoLOCK-C$112,927
- SafeOp$109,472
- Affix$105,865
- Vusion OS$97,580
- nanoLOCK-L$82,440
- IBIS XL$67,919
- Solus ALIF$36,359
- DO NOT USE - TLIF$33,500
- Pulse$31,082
- OsteoCentric 4.0 x 130mm LOCKING BONE SCREW FASTENER ST$28,097
- Spinal Rod$25,780
- Vusion$21,473
- nanoLOCK$19,342
- Endoskeleton$19,342
- IdentiTi$13,167
How this compares
Too few orthopaedic surgery of the spine providers in Utahto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sodium Chloride0.9 % Sodium Chloride | 11 | $696 |
| Methylprednisolone | 21 | $185 |
| Tramadol Hcl | 16 | $50 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Salt Lake City
- William SpikerSalt Lake City$172K
- Omid JalaliSalt Lake City$6K
- Mason YoungSalt Lake City$3K
- Brent FelixSalt Lake City$3K
- Richard Dal CantoSalt Lake City$457
- Aaron ChamberlainMurray$508K
- Michael SteinhausMurray$130K
- Stephen WarnerMurray$21K
- David BarnesSt George$14K
- Christopher KowalskiLogan$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.